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ABSTRACT: The large-scale continuous production of niosomes remains challenging. The inherent drawbacks of batch processes 
such as large particle polydispersity and reduced batch-to-batch reproducibility are here overcome by using commercially available 
microfluidic reactors. Compared to the traditional batch-based film hydration method, herein, we demonstrate that it is possible to 
carry out the homogeneous, large-scale (up to 120mg/min) production of niosomes using two different synthesis techniques (the 
thin film hydration method and the emulsification technique). Niosomes particle size can be controlled depending on the need by 
varying the synthesis temperature. The high cytocompatibility of the resulting niosomes was also demonstrated in this work on 
three different somatic cell lines. For the first time, the structure of the niosome multi-lamellar shell was also elucidated using high-
resolution transmission electron microscopy (HR-STEM) as well as their colloidal stability over time (6 weeks) under different 
storage conditions. The morphology of cryo-protected or as-made niosomes was also evaluated by HR-STEM after freeze-drying. 
Finally, the dual ability of those synthetic, non-ionic, surfactant based vesicles to carry both hydrophilic and hydrophobic molecules 
was also here demonstrated by using laser scanning confocal microscopy. 
INTRODUCTION 
The production of organic nanoparticles (NPs) has not been 
as extensively studied as the production of inorganic ones,1 
which is surprising considering their extended use in the fields 
of pharmaceutics2, nanomedicine3 and food industry.4 The 
most studied production approaches are based on emulsion-
based and nanoprecipitation methods. Both approaches require 
achieving a high mixing performance in order to control the 
NP size and the amount of active principle loaded. In the 
emulsion-based methods the emulsion is an intermediate stage 
where an immiscible organic phase is confined in small drop-
lets, which act as a template for the organic NP formation. The 
organic NPs are finally produced by separating the organic 
solvent via evaporation5 or by diffusion processes with the 
consequent polymer precipitation.1, 6 Nanoprecipitation, on the 
other hand, relies on the creation of a supersaturated solution 
using miscible solvents, by means of a temperature change7 or 
by solvent displacement,8 which ultimately leads to the for-
mation of an insoluble precipitate composed of dispersed 
organic NPs.1  
Organic NPs enhance the solubility of poorly aqueous solu-
ble drugs/biomolecules and enable to control their release by 
means of biological or physical degradation. Consequently, 
special production techniques are required in order to disperse 
non-soluble organic molecules into water, maintain the disper-
sion stable for a certain period of time, control the size and 
functionalize the surface of the resulting organic NPs to mini-
mize aggregation and opsonization during their potential par-
enteral administration.9 These strict requirements pose serious 
challenges to their mass production, including limited batch-
to-batch reproducibility and controllability, in terms of mor-
phological and physicochemical properties.10, 11 A wide variety 
of multistep batch laboratory procedures are not amenable to 
large-scale production because they require time consuming 
post-production steps (e.g., density-gradient centrifugation, 
size-exclusion chromatography, ion-exchange chromatog-
raphy, electrophoresis, selective precipitation, preferential 
solubility, membrane filtration, extraction, etc.) to improve 
size uniformity and maintain a high standard. As a result, there 
is often a balance between maintaining the ability to control 
the desired nanoscale features and achieving high production 
throughput.11 Consequently, the development of new technol-
ogies tackling some of these challenges could significantly 
accelerate the clinical translation of organic NPs. 
Niosomes are the synthetic, non-ionic, counterparts of lipo-
somes, formed by self-assembly of non-ionic surfactants. The 
self-assembly of amphiphilic surfactants into closed bilayers 
to form niosomes is not spontaneous and requires some input 
of well-spatially distributed energy such as ultrasound, heat or 
mechanical shaking. In addition, niosomes are only thermody-
namically stable in presence of appropriate mixtures of surfac-
tants and surface charge inducing agents.12 The basic compo-
nents of niosomes include non-ionic surfactants, a hydration 
medium, charged inducing agents and steroids such as choles-
terol. Charged inducing agents, either positive or negative, are 
used for preventing the aggregation of niosomes since it is 
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 well considered  that zeta (ζ)-potentials over |30| mV are nec-
essary for full electrostatic colloidal stabilization.12 Charge 
inducing agents act by preventing the fusion of niosomes due 
to repulsive forces of the same charge. Cholesterol reduces the 
temperature of the vesicular gel to liquid crystal phase transi-
tion and decreases the overall Hydrophile-Lipophile Balance 
(HLB) value of the surfactant mixture.13 In addition, choles-
terol improves the cohesion of the niosomal membrane to 
decrease its permeability and influences the physical proper-
ties and structure of niosomes because several surfactants form 
vesicles only after cholesterol addition.14 However, cholesterol 
decreases the entrapment volume during formulation, affecting 
the loading efficiency.15 
Since the initial development of niosomes by L`Oreal for 
cosmetic applications in the late 1970s, they have been evalu-
ated in therapeutic applications due to their ability to reduce 
systemic toxicity and minimize clearance. Niosomes are suita-
ble for the delivery of numerous pharmacological and diagnos-
tic agents via different routes2, 12, 16-18 : 1) Dermal and trans-
dermal; 2) Ocular; 3) Oral; 4) Pulmonary and 5) Parenteral. 
Taking into account the enormous prospective of niosomes in 
drug delivery and diagnostics, an increasing research interest 
is arising in stable niosomal formulations because niosomes 
are able to overcome some disadvantages associated with 
liposomes12: 1) surfactants are easily derivatized 2) give a 
higher versatility to control the vesicular structure 3) high 
stability towards oxidative degradation and 4) they have lower 
costs than phospholipids. 
 Niosomes can be prepared as unilamellar or multilamellar 
vesicles, where hydrophilic molecules can be encapsulated 
within their aqueous core, while hydrophobic molecules can 
be partitioned into their lamellar structure. The standard bulk 
methods for niosomal formulation can be summarized as12: 
thin film hydration method (FHM), the organic solvent injec-
tion method, the reverse phase evaporation method and the 
gas-bubble method. However, conventional bulk methods for 
producing niosomes suffer from the poor control over the 
chemical and mechanical environment.1 The lack of control in 
mixing conditions often leads to large niosomes with high size 
polydispersity, thus affecting the envisaged niosome applica-
tion. Post-processing steps such as extrusion or sonication are 
then required to reduce and homogenize their size.  
Microfluidic technology faces those previous limitations and 
leads to improve the mean size and size distributions of nio-
somes by taking advantage of the rapid and controlled mixing 
of reagents. Microfluidic reactors offer a plethora of potential 
advantages for the production of NPs19 and transform current 
classical batch technologies for the production of NPs into 
continuous well-controlled microfluidic process: 1) Accurate 
control and manipulation of fluids and fluid interfaces with a 
homogenous reaction environment; 2) Rapid and uniform heat 
and mass transfer; 3) In-situ monitoring of the progress of NPs 
formation; d) Excellent reproducibility; e) Rapid screening of 
synthesis parameters and f) High-throughput continuous pro-
duction and limited undesirable by-product formation. Alt-
hough the production of niosomes in batch-type reactors has 
been widely studied16, 17, 20, the translation to a controlled and 
continuous process has been scarcely studied.  
Lo et al.21 reported for the first time the continuous produc-
tion of niosomes by a microfluidic hydrodynamic flow focus-
ing system fabricated in Polydimethylsiloxane (PDMS) and 
silicon. Controlling the diffusive mixing time was crucial to 
promote the homogenous assembly of niosomes with smaller 
sizes and more monodisperse in size distribution than the ones 
retrieved from conventional bulk methods. The synthesis 
procedure described was based on the thin film hydration 
method. In this method, the surfactants and additives are dis-
solved in an organic solvent in a round-bottom flask.22 The 
thin film is formed on the inside wall of the flask by removing 
the organic solvent. Finally, an aqueous/alcoholic solution is 
added and the dry film is hydrated above the transition tem-
perature of the surfactant to promote the formation of nio-
somes.22 According to Lo et al.21  it was first required the 
production of a Span-cholesterol-DCP (dicetyl phosphate) dry 
film and the subsequent resolubilization in isopropyl alcohol 
(IPA). The niosome assembly was promoted by the mixing of 
two miscible fluids IPA and a hydration buffer. The results 
achieved were remarkable, but the dry-film preparation is a 
time consuming stage that hampers the high-throughput pro-
duction of niosomes when using a continuous approach. This 
reported method has been considered recently as an inspiration 
for the production of non-ionic surfactant vesicles by a hydro-
dynamic microflow system,23 but using lipids instead of the 
well-studied surfactants used for niosome preparation (Span, 
Tween or Brij).22  
In this study, we present a new method of niosome self-
assembly by microfluidic hydrodynamic focusing without the 
need of a size reduction step, as required in the conventional 
methods. The microfluidic system is a commercial micromixer 
that can enable an easy reproduction of the reported results. 
This fact is of enormous importance because the majority of 
microfluidic systems reported in organic nanomaterial synthe-
sis are custom made microfabricated silicon/PDMS-based 
reactors with a limited access by non-microfluidic skilled 
users. The novelty of this work is based on the production of 
niosomes in continuous flow without the need of a thin film 
formation and by using an emulsification process. This strate-
gy exerts the advantage of reducing the timeline reported by 
Lo et al.21, increasing considerably the production throughput 
and avoids the use of a toxic solvent during the thin film evap-
oration. This study has selected sorbitan esters (Span) as non-
ionic surfactants because they are FDA approved additives for 
use in food processing and pharmaceuticals21. The proposed 
method has been benchmarked with the thin film formation 
technique assisted by microfluidics and by using batch-type 
reactors. Niosomes have been characterized by the first time 
using high-resolution electron microscopy, obtaining excellent 
information about the bilayers structure. Confocal microscopy 
was carried out to verify that dual hydrophilic and hydropho-
bic molecules could be loaded in niosomes. In vitro cytotoxici-
ty experiments were subsequently performed to evaluate the 
subcytotoxic dose of the produced niosomes on different cell 
lines.  
EXPERIMENTAL SECTION 
Reactants.Cholesterol, Sorbitan monolaurate-Span20, Dice-
tyl phosphate (DCP), Nile Red, Fluorescein, Phosphotungstic 
acid, 2-propanol (IPA) and Ethyl acetate were purchased from 
Sigma-Aldrich (St. Louis, MO) and used as received.  
Film hydration method in batch type reactors. Niosome 
formation was carried out using a modification of the proce-
dure reported by Paolino et al.24  as here briefly described 
(Figure 1-a). A mixture of 52 mg of Span20, 58 mg of Choles-
terol and 8.6mg of DCP (47.5:47.5:5 molar ratio) was dis-
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 solved in 400 µL of ethyl acetate and mixed at 60ºC in a glass 
scintillation vial during 5 min. The organic solvent was then 
evaporated under N2 reflux during 4 h to obtain a dry film on 
the bottom of the scintillation vial. After that, sample was 
leftovernight in a desiccator to achieve the total organic sol-
vent evaporation. After 12 h of drying, the dry film was re-
solubilized with 400 µL of IPA at 60ºC during 5 min. Nioso-
mal suspension was mixed with 20 mL of milli- Q water at 
35ºC and subjected to ten cycles of sonication during 1 min. 
each using a Branson Digital Sonifier (Model 450) operating 
at 30% of amplitude output following a 0.5 min pause between 
each sonication. The resulting homogeneous emulsion was 
then kept under mechanical stirring during 1h to allow the 
evaporation of the organic solvent present in the sample.  
Film hydration method in microfluidic reactors. The dry 
film was prepared as it was previously described in the batch 
type procedure. 400 µL of IPA were added to the dry film to 
obtain a complete resolubilized solution. The organic phase 
was loaded in a syringe and injected with a flow rate of 15.7 
µL/s. The aqueous phase was injected with a flow rate of 
768.3 µL/s. The micromixer promoted the phase multilamina-
tion and then, the subsequent niosome self-assembly (Figure 
1-b). 
Emulsification method in microfluidic reactors. A mix-
ture of 52 mg of Span20, 58 mg of Cholesterol and 8.6 mg of 
DCP (47.5:47.5:5 molar ratio) was dissolved in 400 µL of 
ethyl acetate and mechanically mixed at 60ºC in a water bath 
during 5 min. The prepared solution was loaded in a syringe 
and injected in the interdigital micromixer with a 15.7 µL/s 
flow rate. The temperature in the syringe was kept constant to 
prevent reagents precipitation. An additional stream of Milli-Q 
water at different temperatures (25 ºC-55 ºC) was injected in 
the micromixer with a flow rate of 768.3 µL/s (Figure 1-b).  
The outlet stream was collected in a glass vial and kept under 
mechanical stirring during 15 minutes to allow the evaporation 
of the organic solvent.  
The hydrophilic/hydrophobic loading potential of niosomes 
was studied by loading two types of fluorescent dyes (Figure 
1-c): 1) Hydrophobic-Red Nile was dispersed in the organic 
stream, 0.1 mg/mL. 2) Hydrophilic, sodium fluorescein was 
added to the aqueous stream 0.1 mg/mL. 
Microfluidic reactors. Niosomes were prepared using a 
Polyether ether ketone (PEEK) slit interdigital micromixer 
with an inner volume of 8 µL (Micro4Industries GmbH, 
Mainz, Germany) interfaced with Polytetrafluoroethylene 
(PTFE) tubing (OD = 1/16”, ID = 1 mm) (Figure 1-b). The 
slit-interdigital micromixer follows the principle of producing 
thin liquid lamellae, guiding the inlet streams in contact 
through a flow-through-chamber. The organic and aqueous 
phase streams were introduced in the micromixer by means of 
syringe pumps (Harvard Apparatus PHD Ultra ™ CP 4400), 
ensuring a good control of the flow rates with very low pulsa-
tion. The injected streams were split into 16 substreams of 45 
µm width each. Substreams were later on recombined to in-
crease the contact surface between the two immiscible phases 
to produce the emulsification process and the assembly of the 
niosomes.  
Niosomes characterization.  
Dynamic light scattering. The hydrodynamic diameter and 
size distribution of the resulting niosomes were determined by 
dynamic light scattering measurements using a Brookhaven 90 
Plus (Holtsville, NY) equipment. 100 µL of the niosomal 
suspension were suspended in 1.5mL of distilled water and 
sonicated before measurements. Each sample was measured 
three times to obtain a significant value. 
Zeta potential measurements. The zeta potential of niosomes 
was directly related to their surface charge density and was 
measured by using a Brookhaven 90 Plus equipment. Zeta 
potential values were determined using 100 µL of the niosome 
sample and adding 1.0 mL of 1mM KCl at pH 7.4. Three 
repeated measurements of the Z potential were performed for 
each individual experiment. 
Morphological studies. The morphological characterization of 
the resulting niosomes was performed at the LMA-INA facili-
ties in a Transmission Electron Microscope TEM (TECNAI 
FEI T20) operating at an acceleration voltage 200 kV with a 
LaB6 electron source fitted with a “SuperTwin®” objective 
lens allowing a point-to-point resolution of 2.4 Å. Aberration 
corrected scanning transmission electron microscopy (Cs-
corrected STEM) images were acquired using a high angle 
annular dark field detector in a FEI XFEG TITAN electron 
microscope operated at 300 kV equipped with a CETCOR Cs-
probe corrector from CEOS. The niosome samples were 
stained with 7% (w/v) phosphotungstic acid as a negative 
contrast to facilitate bilayer observation. Particle size histo-
grams were obtained according to best practices in determina-
tion of nanoparticle size distribution25.Confocal microscopy 
was carried out to verify the hydrophilic and hydrophobic 
molecule loading in niosomes. A drop of the produced emul-
sion of niosomes was mounted on microscopy slides and visu-
alized by confocal microscopy (Leica TCS SP2 Laser Scan-
ning Confocal Microscope, Microscopy Unit, CIBA, IIS Ara-
gon, Spain). Empty control samples were also tested to dis-
miss sample autofluorescence. 
Biocompatibility studies. 
Cell cultures. Fibroblasts, macrophages and keratinocytes 
were used as cell models to test the cytotoxicity of the result-
ing niosomes. Human dermal fibroblasts were purchased from 
Lonza (Belgium), THP1 human monocytes were obtained 
from the American Type Culture Collection (USA) and human 
epidermal keratinocytes (HaCat) were kindly donated by Dr. 
Pilar Martin-Duque.  
Fibroblasts and HaCaT were grown in high-glucose DMEM 
(DMEM w/stable glutamine; Biowest, France) supplemented 
with 10% fetal bovine serum (FBS; Gibco, UK), penicil-
lin/streptomycin (100 U/100 µg/mL; Lonza, Belgium), and 
amphotericin B (1.5 µg/mL; Lonza, Belium). Monocytes were 
cultured in RPMI 1640 (RPMI 1640 w/stable glutamine; 
Biowest, France) supplemented with 10% FBS, 1% HEPES, 
1% nonessential amino acids, 0.1% 2-mercaptoethanol, 1% 
sodium pyruvate 100mM, penicillin/streptomycin (100 U/100 
µg/mL), and amphotericin B (1.5 µg/mL), all purchased from 
Gibco (UK). Macrophages were obtained by the in vitro dif-
ferentiation of monocytes by adding 1 µM phorbol 12-
myristate 13-acetate (PMA) (Sigma-Aldrich, USA) to the cell 
culture. All cell types were grown in humidified atmosphere at 
37ºC and 5% CO2.  
Cell cytotoxicity. The cytotoxicity of niosomes in the cellu-
lar metabolism was studied by the Alamar Blue assay (Invi-
trogen, US). Fibroblasts, macrophages and keratinocytes were 
seeded in a 96-well plate and incubated with 0.01- 0.4 mg/mL 
of niosomal dispersions in water for 24h. Alamar Blue was 
then added (10%) and incubated for 4h. If the metabolism of  
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Figure 1.- a) Scheme of niosome synthesis by the thin film hydration method: 1) Mixing of noisome reagents, 2) Dry film formation, 3) 
Dry film dispersion and 4) Niosomes formation by solvent evaporation. b) Slit micromixer selected to produce niosomes in continuous 
fashion either by the film hydration method or by emulsification. c) Scheme of a multilamellar niosome and hydrophilic/hydrophobic 
loading scenario.  
cells were active, the dye would change to a fluorescent 
compound which was read in a microplate reader (Multimode 
Synergy HT Microplate Reader; Biotek, US) at 535/591 nm 
ex/em. Cell viability was determined by interpolation of the 
emission data obtained from the treated samples and samples 
without nanoparticles (considered as the 100% of viability). 
Statistical analysis. Statistical analysis was carried out us-
ing GraphPad Prism 7 for Windows (GraphPad Software, La 
Jolla, CA, USA). Three replicates for each experiment were 
performed and the results were analyzed as mean ± standard 
deviation. A p value ≤ 0.05 was considered as significant, p < 
0.01 highly significant. Two-way ANOVA analysis was used 
for multiple comparisons using Dunnett statistical hypothesis 
test. 
RESULTS AND DISCUSSIONS 
Synthesis of niosomes by batch and continuous ap-
proaches. 
The most widely used method to produce niosomes is based 
on the thin-film hydration method where the surfactants and 
additives such as cholesterol are dissolved in an organic sol-
vent in a round bottom flask. Then, a thin film is formed on 
the inside wall of the flask by removing the organic solvent 
using a rotary vacuum evaporator. To form the niosomes, an 
aqueous/alcoholic solution is then added and the dry film is 
hydrated above the transition temperature (Tc) of the surfac-
tant, obtaining a white suspension (Figure 2-a). Dynamic light 
scattering of niosomes produced in the batch reactor, using the 
thin-film hydration method by the assistance of a highly ener-
getic homogenization technique such as probe sonication at 
60ºC, rendered vesicles of 339±42 nm with a polydispersity 
index (PDI) of 0.137 and a zeta-potential of -75±7 mV (Table 
1). The PDI <0.2 indicates that the distribution consisted of a 
single size mode without showing aggregates. This high Zeta-
potential value is in agreement with the literature26 and ensures 
that the vesicles will repel each other and resist aggregation. In 
order to gain information concerning the morphology of the 
niosomes produced by the film hydration in batch, negative 
stained niosomes were analyzed by transmission electron 
microscopy as shown in Figure 2 a and b. TEM imaging of 
resulted niosomes evidenced the formation of round-shaped 
vesicles with a multilamellar structure formed by the assembly 
of hydrophobic and hydrophilic segments of the surfactant 
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 Span 20, as it is depicted in Figure 1-c. The average diameter 
of the niosomes obtained from these images (187±55 nm, Fig 
S1-a) is found to be well correlated with that obtained from 
DLS measurements. Although the size measurements deter-
mined by TEM are smaller than in DLS due to the lack of 
hydration. The production of niosomes by the film hydration 
method, but assisted by vortex instead of ultrasound is report-
ed to render a heterogenous particle-size distribution with a 
polydispersity index of 0.3.24 This lack of control is due to a 
non-controlled shear stress to promote the proper assembly. 
Then, to suppress this limitation it is required the use of highly 
energetic homogenization techniques such as probe sonication. 
However, the sonication process presents a serious limitation 
for scaling-up the production of nanomaterials because the 
intensity of the ultrasound in a liquid decreases rapidly with 
the distance to the sonotrode.10 It implies that larger volumes 
might not be well homogenized, providing a heterogeneous 
distribution of acoustic waves and consequent niosomes poly-
dispersity. 27 In addition, it is reported that the cavitation gen-
erated during the ultrasonication process can etch the sono-
trode tip surface, promoting a feasible product contamination 
with ions or particles from the sonotrode.27 This phenomenon 
could be serious if the produced vesicles were aimed to be 
used in biomedical applications. 
Considering that microfluidics enable a fast diffusion mixing 
by producing thin liquid lamellae,19 we propose in this work to 
use a commercial slit-interdigital micromixer as a tool to as-
sembly niosomes in a continuous flow (Figure 1-b).  Lo et al.21 
reported the use of a hydrodynamic flow focusing microreac-
tor to promote the fast self-assembly of niosomes and improve 
the control on their size distribution. This new approach was 
based on their procedure and the fast mixing achieved in the 
microchannels.21 Niosomes were assembled by injecting the 
previously prepared thin film and dispersed in isopropyl alco-
hol into two adjacent PBS streams that enabled a hydrodynam-
ical flow pattern.21 Besides the excellent results achieved by 
Lo et al.21, the reactor throughput was very limited (100 
µl/min) and the microreactor was not commercially available 
with a limited access by non-microfluidic skilled users. As a 
contrary, the reactor proposed in this work is commercially 
available, enabling an easy reproduction of the reported re-
sults. In addition, the limited throughput was solved by a 
numbering-up approach, where 32 parallel microchannels 
were used  
 
Table 1.-Comparion of niosome characteristics prepared 
by different approaches in terms of size, polydispersity 
index and surface charge 
Synthesis 
approach 
Niosome size 
DLS, (nm) 
Polydispersity 
Index 
Surface 
charge 
(mV) 
Film hydration 
method | batch 
reactor 
339±42 0.137 -75±7 
Film hydration 
method | mi-
cromixer 
253±46 0.156 -35±1 
Emulsification 
|micro-mixer 
238±41 0.135 -33±3 
instead of the 3 channels used by Lo et al.21 . The here pro-
posed micromixer was previously applied by our group to 
successfully produce polymeric poly(lactic-co-glycolic acid) 
PLGA nanovesicles with a mean size of 211±62 nm.10 
 
Figure 2.- TEM images of niosomes produced by different ap-
proaches. Thin film hydration method in batch reactor assisted by 
ultrasounds: (a) Overview of niosomes; (b) High magnification 
image of a multilamellar niosome. Thin film hydration method in 
a microfluidic mixer: (c) Overview of niosomes; (d) High magni-
fication images of multilamellar niosomes. A compressed nio-
some is depicted, highlighting the high deformability index of this 
type of vesicles. Emulsification method in a microfluidic mixer, 
residence time = 10 ms, Tª = 55 ºC): (e) overview of niosomes; (f) 
High magnification image, observing the multilayer of SPAN and 
cholesterol over the whole particle. (g) Production of niosomes by 
the emulsification method with a micromixer (collecting time 90 
s). (h) Comparison of niosome productivity between the film 
hydration method and the emulsification approach. 
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 Those PLGA nanovesicles were formed under a residence 
time as short as 10 ms and a total flow rate of 48 ml/min.10 
In this work, the hydrated thin film was dispersed in isopro-
pyl alcohol and was split in 16 streams by using a commercial 
slit-interdigital micromixer. On the other hand, an aqueous 
stream was equally diverged into 16 slits, flowing thin aque-
ous laminated streams into the isopropyl alcohol streams and 
following a 90° trajectory to accelerate the mixing of miscible 
streams. The narrow width of the focused streams enables 
rapid mixing through diffusion. The mixing time (τmix) can be 
estimated for hydrodynamic flow focusing using a two-
dimensional model as Equation 1. 28   
 
Equation. 1         
 
 
where D is diffusivity of the solvent (10-9 m2·s-1), w is the  
microchannel width, and FRR is the ratio of flow rate of the 
water to isopropyl alcohol. It was observed that the increase of 
FRR from 15 to 50 resulted in a narrow niosome size distribu-
tion.21 Consequently, the total volumetric flow rate, at a con-
stant FRR (FRR= 50), was modified in the slit-interdigital 
micromixer to study whether a change in the residence time 
can enhance the diffusion mixing and render homogenous 
sized niosomes with a high production throughput. The total 
volumetric flow ratio was tuned from 0.48 ml/min to 48 
ml/min, ranging the resulting residence time (tm) from 1 s to 
0.01s, respectively. Considering that the τmix (Equation 1) at a 
FRR = 50 was 8.10-2 ms, the range of total flow rates selected 
were large enough to promote the assembly of niosomes. 
Dynamic light scattering of produced niosomes elicited a 
reduction of mean particle size from 2361±1109 nm to 253±46 
nm as the residence time was decreased from 1 s to 0.01 s, 
respectively. This result is in agreement with computational 
fluid dynamic analysis of the slit-interdigital micromixer used, 
where large flow rates promote a diffusive mixing enhance-
ment that enables the production of nanovesicles instead of 
microvesicles.10 Table 1 shows that the mean particle size 
achieved with the slit-interdigital micromixer at tm= 0.01s  
(253±46 nm) is smaller than that achieved with the batch-
ultrasound assisted process. However, the PDI (PDI=0.156) of 
niosomes produced with the micromixer is slightly larger than 
the ones obtained with the batch-ultrasound assisted process, 
inferring from this result that the size distribution with the 
micromixer is less homogeneous.  
Regarding the niosome surface charge produced with the 
micromixer, there is a sharp decrease in the Zeta-potential 
value, obtaining niosomes with a surface charge of -35 ±1 mV. 
This difference can be associated with a lower inclusion of the 
charge inducing agent (DCP) in the lamellar structure. How-
ever the Zeta-potential value is higher than -30 mV and then, 
the colloidal niosomes are still stable for any desired biomedi-
cal use.12 TEM images in Figure 2-c and d show that the mor-
phology and lamellar structure is similar to the one achieved 
with the batch-ultrasound assisted process. The average di-
ameter of the niosomes obtained from these images (298±49 
nm, Fig S1-b) is found to be well correlated with that obtained 
from DLS measurements. Considering that the synthesis of 
niosomes by the film hydration method is as semi-continuous 
procedure, the estimated productivity at the largest flow rate 
(48 ml/min) was 18 mg/min. Then, the productivity of nio-
somes is larger than the one achieved by Lo et al.21 (100 
µl/min), but it is still limited due to the multiple steps required 
to prepare the thin film composed by surfactant and additives. 
To face this shortcoming, we propose a novel strategy where 
the niosome reagents are injected in a single step at the mi-
cromixer and assembled by emulsification to render vesicles. 
 Two non-miscible streams were injected at the slit-
interdigital micromixer to render a controlled emulsification 
process (Figure 1-b): 1) Organic stream. SPAN-20, DCP and 
cholesterol were dispersed in ethyl acetate and 2) Aqueous 
stream, composed of Milli-Q water. The reagent composition 
of the streams injected at the micromixer was similar to the 
one selected by the film hydration method, but using ethyl 
acetate instead of isopropyl alcohol. At the proper flow rates, 
the shear stress produced at the interphase of immiscible liquid 
microflows is energetic enough to promote the emulsion for-
mation without the need of external mechanical or ultrasonic 
forces.10 Finally, the organic solvent was evaporated to obtain 
the niosomes. This procedure is based on the well-known 
reverse phase evaporation technique, bypassing the time con-
suming operation of thin film-hydrated preparation, as well as 
enabling continuous niosome production.  
Differently to reverse phase evaporation technique, the pro-
posed procedure does not require vigorous conditions with 
high energetic sonication. Based on our previous work about 
the emulsification of poly(lactic-co-glycolic acid) PLGA with 
ethyl acetate and water as non-miscible solvents10, as well as 
the balance of high viscous shear stress and surface tension, 
emulsification of niosomes reagents was carried out at the 
highest flow rate achievable with the pumping setup (48 
ml/min). This flow rate implies that the residence time of the 
injected reagents at the slit-interdigital micromixer was 10ms. 
Interestingly, the direct assembly of niosomes by emulsifica-
tion rendered multi-lamellar niosomes with similar morpholo-
gy and microstructure than the ones achieved by the film hy-
dration method either in batch, assisted by ultrasounds, or in 
the micromixer (Figure 2 e-f). The average diameter of the 
niosomes obtained from these TEM images (181±39 nm, Fig 
S1-c) was found to be well correlated with that obtained from 
DLS measurements. A detail TEM image with high magnifi-
cation enables to resolve an onion-like organization of the 
niosome membrane (Figure 2-f). Dynamic light scattering 
unveiled that the size of produced niosomes (238±41 nm) was 
smaller than those obtained with previous procedures. The 
PDI (0.135) was similar to the one achieved with sonication 
(0.137), inferring from this result that microfluidic technology 
is an alternative to high energetic procedures, but it leverages 
for the continuous, non-contaminated and controlled produc-
tion. Regarding the surface charge of niosomes produced by 
emulsification, it is similar to the one produced by the film 
hydration method with the micromixer. Finally, the produc-
tivity achieved by the emulsification methods clearly over-
passes the productivity of previous reported procedures, ob-
taining a throughput of 120 mg of niosomes/min.  
Electronic microscopy characterization of niosome bi-
layers. 
Considering that a detailed description of the niosomes struc-
ture by electron microscopy is scarce and there is a limited 
amount of available data, we aim to provide insight into their 
bilayer structure by imaging techniques. As far as we know, 
niosomes were never studied before using high resolution 
scanning transmission microscopy. Figure 3 shows STEM-
HAADF images of negative stained niosomes produced by the  
 ≈
2
9	
·
1
(1 + )2
 
Page 6 of 13
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  
Figure 3.- STEM-HAADF images of the niosome nanostructure. The niosomes were produced using the emulsification process at a resi-
dence time of 10 ms and 55 ºC. The niosomes were negatively stained with phosphotungstic acid: a) The collapsed structure of a niosome 
after drying. b) Magnification image to confirm the presence of a multilamellar shell and a hollow inner structure. c) Detail image of the 
bilayer shells of two contiguous niosomes. d-e) High resolution images of the niosome bilayer at different locations. f) High resolution 
image of niosome bilayers. Bilayer thickness determination by imaging profile (red dashed line) and interpretation of the Span 
20/Cholesterol bilayer according to molecular simulations.29 
emulsification method. The collapsed structure of the niosome 
after drying confirms the presence of a multi-lamellar shell of 
approx. 12 nm and a hollow structure (Figure 3 a-c). This 
result is in agreement with previous observations,22, 30 where it 
is shown that niosomes are capable of encapsulating both 
hydrophilic and lipophilic substances. The hydrophilic mole-
cules are entrapped in the vesicular aqueous core or adsorbed 
on the bilayer surfaces while the lipophilic substances are 
encapsulated into the lipophilic domain of the bilayers (Figure 
1-c).22 High resolution STEM-HAADF images elicited the 
microstructure of the niosome wall, evidencing the presence of 
3 bilayers (Figure 3 d-e). The stability of the bilayers as well 
as their rigidity are essentially governed by the hydrogen 
bonding between the ester group of Span20 and hydroxyl 
group of cholesterol.31 According to Figure 3-f, the estimated 
dimension of each bilayer is 3.35±0.15 nm and it is in agree-
ment with molecular simulations29 and experimental data 
where the area per molecule of Span 20 is approximately 
22Å2.32 This result is also in agreement with the thickness of 
some reported bilayers: 1) 4.18 nm,29 composed of Span 60 
and cholesterol, 2) 3.49 nm,29, 33 composed of Span 80 and 
cholesterol and 3) 3.53 nm,33 composed of DOPC (1,2-
dioleoyl-sn-glycero-3-phosphocholine) and cholesterol. 
 
 
Effect of hydration temperature on niosomes. 
One of the important parameters that has a direct effect on the 
niosome formation is the processing temperature.22 The hydra-
tion temperature used to produce niosomes should usually be 
above the gel to liquid phase transition temperature (Tc) of the 
surfactant. Considering that the Tc of Span-20 is 16 ºC,
34 we 
have studied the influence of the processing temperature dur-
ing the emulsification process at a range of temperatures > 
16ºC. Figure 4 depicts the TEM images of resulting niosomes 
obtained at mixing temperatures of 25, 35, 45 and 55 ºC. TEM 
images reveals that niosomes are produced in all the range of 
temperature tested. Their morphology is similar in all condi-
tions, obtaining a multi-lamellar structure. However, the di-
mension of the niosomes is sensitive to the hydration tempera-
ture, observing larger niosomes as the temperature was in-
creased. Particle-size distribution histograms resulted from 
TEM images analysis (Fig. S2) show that the mean niosome 
sizes were: 108±24 nm at 25 ºC,   201±43 nm at 35ºC,   
232±39 nm at 45ºC,   and 228±39 nm at 55 ºC. Dynamic light 
scattering of the produced niosomes elicited the TEM ob-
served tendency: 224.0±25.5 nm at 25 ºC, 255.7±28.2 nm at 
35 ºC, 284.3±37.0 nm at 45 ºC and 361.7±38.2 nm at 55 ºC. 
On the other hand, the surface charge was similar in all of 
them with a mean value of -38.9 ± 6.3 mV. The results ob-
served are in agreement with previous results where the effect  
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 Figure 4.- Effect of hydration temperature on niosomes. TEM 
images showing niosomes synthesized by the emulsification 
technique, under temperature changes of the aqueous phase. Low 
magnification images to observe the niosome size distribution and 
high magnification images where the bilayer structure is depicted 
of niosomes produced at: (a-b) 25 ºC); (c-d) 35 ºC; (e-f) 45 ºC); 
(f-g) 55 ºC.  
of temperature on sorbitan surfactant monolayers was ob-
served.32 Generally, as the temperature is increased, the col-
lapse temperature of surfactant Span-20, Span 40 and Span 60 
is lowered, inferring from this fact that the films were more 
expanded as the temperature was increased.32 
Consequently, it seems coherent that a more expanded struc-
ture can give rise to larger niosomes. This evidenced that the 
hydration temperature is one of the key factors to control the 
size of niosomes. In addition, and considering that the final 
application of niosomes is intended for a biomedical use, the 
layers produced at a high temperature are less stable than the 
ones produced at low temperatures (over the Tc).
32 
Study of niosome stability. 
Niosomes stability was assessed by monitoring changes in 
size for the resulting vesicles over time, to predict their swell-
ing, degradation or potential aggregation characteristics. Hy-
drated bilayers of niosomes are not considered to be thermo-
dynamically stable35, and then, niosomes can exhibit changes 
during long-term storage. To investigate the stability of the 
niosomes, they were dispersed in PBS and stored in glass vials 
at room temperature and in the refrigerator (4 ºC), for a period 
of 6 weeks. The hydration media has a key effect on niosome 
stability26, being more stable in aqueous media than in saline 
solutions36. Niosomes were dispersed in PBS in order to test 
the most comparable conditions to a physiological media for 
the hydrated bilayers. For niosomes prepared with microfluid-
ic reactors by the emulsification and film hydration method, 
the particle size showed a decrease in the first week, and then 
remained stable throughout the study when niosomes were 
indifferently stored at 25ºC or at 4ºC (Figure 5-a). Niosomes 
produced by the emulsification method underwent a 30% size 
reduction rate during the first week of storage, whereas nio-
somes produced by the film hydration method exhibited a 20% 
size reduction.  
The size reduction can be directly related with the osmotic 
pressure through the niosome bilayers. This phenomenon has 
been previously observed in liposomes, where a saline solu-
tion exposure reduces the dimension with a size variation ratio 
of up to 0.2 in response to osmotic forces37, 38. The shrinkage 
in liposomes size was also previously observed during an 
initial period of time (12h) and then, no size variations were 
observed37, 38. The reduction in niosome size also causes the 
hydrated bilayers to compress and this could affect their stabil-
ity. TEM images depicted in Figure 5 also confirm the reduc-
tion in size for both emulsification (61 and 44 nm for cold and 
room temperature storage, respectively) and film hydrated (72 
and 71 nm for cold and room temperature storage, respective-
ly) approaches. However, the structure of hydrated bilayers 
after 6 weeks in PBS was still stable and a multi-lamellar shell 
of approximately 12 nm was observed. This result is coherent 
with the previous literature where the presence of DCP and 
cholesterol improved the physicochemical properties of nio-
somes and assured their bilayer stability4. On the other hand, 
there were no significant changes in the surface charge of 
niosomes regardless of the storage temperature. This fact is in 
agreement with the aforementioned bilayer stability and the 
physicochemical role of DCP and cholesterol. 
On the other hand, the stability of niosomes produced by the 
emulsification method in the microfluidic system were studied 
in DMEM as culture media. As can be inferred from Table S1, 
no significant changes in particle size were observed after 
three weeks. DMEM is a high glucose culture medium sup-
plemented with 10% fetal bovine serum that promotes the 
niosome stabilization probably because a protein corona is 
surrounding the surface of the niosomes and avoids any size 
reduction. 
 Niosome formulations are preferred to be stored at low 
temperature because the retention of encapsulated active bio-
molecules or drugs is diminished as the storage temperature is 
increased39. This fact is due to the degradation of surfactants in 
the bilayers, resulting in defects in the membrane packing40. 
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Figure 5.-  Stability of niosomes prepared by emulsification 
(residence time of 10 ms and 55 ºC) and film hydration, using 
PBS as hydration media and a stored temperature of 4 ºC and 25 
ºC. The data represents the mean ± SD measured by DLS. TEM 
images of niosomes stored during 6 weeks with PBS; niosomes 
synthesized by the film hydration method using microfluidics, 
stored at: b) 25 ºC, c) 4 ºC. Niosomes synthesized by emulsifica-
tion, stored at: d) 25ºC, e) 4ºC 
To address this lack of retention control, niosomes are usual-
ly lyophilized either with a cryoprotectant such as mannitol41 
or even just without a cryoprotectant39. Figure 6 depicts the 
niosomes produced after lyophilizing by freezing the niosome 
dispersion at −70 °C and drying under vacuum for 24 hours. 
Lyophilized niosomes tended to assembly into short chains of 
approx. 500 nm in diameter and few vesicles length. The vesi-
cles still kept the niosome bilayer structure as it is depicted in 
Figure 6-b. The niosome assembly was also produced if a 
cryoprotectant were also used (Figures 6-c,d). These results 
imply that niosome could fuse during the lyophilization condi-
tions to generate niosome assemblies. This phenomenon was 
previously reported to enhance the drug loading in niosomes34, 
but no electronic imaging evidences were provided to support 
this niosomal fusion. The same mechanism was also reported 
by Ohsawa et al.42, using the well-known freeze-drying meth-
od to enhance the encapsulation of biomolecules and drugs in 
liposomes. The mechanism explained to promote the encapsu-
lation during the freeze thawing cycle is based on34, 39: 1) the 
drug and vesicles are concentrated while freezing, 2) vesicles 
were closely packed with each other resulting in their fusion 3) 
new vesicles are formed, enhancing the efficient entrapment of 
drugs or active biomolecules. 
 Figure 6.-TEM images of lyophilized niosomes produced by 
emulsification at a residence time of 10 ms and 55 ºC: a-b) with-
out cryoprotectant; c-d)with mannitol (2.5 wt.%) as cryoprotect-
ant. 
Cytotoxicity studies 
The cytocompatibility of the synthesized niosomes (0.01-0.4 
mg/mL) from both methodologies was assessed in three cell 
lines related to skin (human dermal fibroblasts, keratinocytes 
and macrophages), due not only to their potential cosmetic use 
but also to their feasible dermal and transdermal delivery of 
compounds with therapeutic or diagnostic purposes. Figure 7 
depicts the viability percentages estimated by the Alamar Blue 
assay after incubation for 24 h of the cell types assayed with 
niosomes obtained from TFH methodology (Figure 7a) and 
emulsification (Figure 7b). In both cases, viability was always 
higher than 70%, which is the minimum concentration rec-
ommended of the ISO 10993-543 for these types of materials in 
which viabilities higher than 70% are considered cytocompat-
ible. Specifically, fibroblasts displayed percentages around or 
higher than 90% while keratinocytes reached values between 
95-100%, pointing to the high cytocompatibility of the nio-
somes tested. On the other hand, macrophages showed a de-
crease in viability with the increase in niosomes concentration 
up to 65-70% at the highest concentration assayed (0.4 
mg/mL), which may be related to the phagocytic role of this 
cell line44. 
Even though little is known about niosomes cytotoxicity, 
previous studies have also shown the high cytocompatibility of 
niosomes containing Span 60 in human lung carcinoma cells 
but at much lower concentrations than ours (≤ 12 µg/mL)45. 
Other authors have also used Span 20-niosomes with transfec-
tion purposes showing successful results in HeLa cells46 or 
even with anti-inflammatory purposes in NCTC2544 human 
keratinocytes pointing to not significant mortality percentages 
up to a concentration of 1 µM when Tween 85 was the surfac-
tant used47. Taken together these studies and our observations, 
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 niosomes appear as a good tool for novel biomedical strate-
gies. 
 
 
Figure 7.- Cell viability of fibroblasts, macrophages and 
keratinocytes in the presence of 0.01-0.4mg/mL of niosomes after 
24 hours incubation following: (a)  the film hydration method and 
(b) the emulsification method. 
Co-encapsulacion of model fluorescent molecules. 
Lamellarity was also qualitatively assessed using confocal 
laser scanning microscopy (CLSM) in order to use the pro-
duced niosomes for a potential dual drug delivery application. 
The preferential distribution of hydrophobic (Nile red) and 
hydrophilic (sodium fluorescein) model fluorescent molecules 
within niosomes was investigated. As it is depicted in Figure 
1-c, Nile red should be selectively attached to the tail group of 
Span 20 amphiphilic bilayers; whereas fluorescein should be 
located at the hydrophilic niosome core close to the hydro-
philic head group of Span 20. CLSM visualization of single 
niosomes was not possible due to the reduced resolution of 
this imaging technique (i.e., <200nm). However the analysis 
of fused niosomes unveiled that the hydrophobic and hydro-
philic dyes were successfully loaded in the same vesicle (Fig-
ure 8 a,b). Figure 8-c depicts the overlapped image of loaded 
dyes to show the uniform encapsulation at the core and at the 
shell. The bright green spots located at the shell are believed to 
be aggregates of single niosomes (Figure 8-d), where the hy-
drophilic core has a brighter emission than the one produced 
by the few hydrophobic bilayers (10-15 nm) where Nile red is 
entrapped. These results are in agreement with previously 
reported results36 based on the dual encapsulation by the film 
hydration method, and confirm that hydrophilic and hydro-
phobic groups of Span20 could be successfully used to simul-
taneously encapsulate hydrophobic and hydrophilic drugs. 
Consequently, the simultaneous encapsulation of molecules of 
different polarity here demonstrated  
 
Figure 8.- Encapsulation of Nile red and sodium fluorescein in 
niosomes produced by the emulsification method at a residence 
time of 10 ms and 55ºC): (a) red channel (Nile red) (b) green 
channel (sodium fluorescein), and (c) overlapped image of red 
and green channels, (d) high magnification image of overlapped 
red and green channels of the area marked in (c). 
might be extended to the co-administration of drugs of differ-
ent nature overcoming the associate limitations of drug solu-
bility and also favoring the potential synergistic action of 
different drugs contained in the same carrier. In addition, it is 
well known that the stratum corneum is largely hydrophobic 
and the use of a carrier able to deliver transdermally hydro-
philic drugs represents a clear advantage of niosomes as carri-
ers in topical delivery 
CONCLUSIONS 
HRTEM, confocal microscopy and dynamic light scattering 
analyses have corroborated the successful synthesis of niosomes 
in a continuous manner with high particle monodispersity. Com-
pared to the traditional batch process the microfluidic synthesis 
here reported produces much more yield in shorter periods of time 
with enhanced monodispersity. The subcytotoxic doses on three 
different somatic cell lines have been evaluated displaying high 
cytocompatibility even at the highest doses tested. Aging and 
freeze-drying effects have been evaluated on the resulting nio-
somes. The niosomes here described are able to carry both hydro-
philic and hydrophobic molecules highlighting their potential 
application as dual drug delivery carriers. 
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